DILIsym Services Inc., a Simulations Plus Company, Releases DILIsym® Version 7A
Significant update of liver safety program includes performance and capability enhancements
Simulations Plus Reports First Quarter FY2018 Financial Results
Consolidated net income up 26.0%; diluted earnings per share increased 22.8%
Simulations Plus Sets Date for 1st Quarter 2018 Earnings Release and Conference Call
Conference Call to be on Tuesday, January 9, 2018, at 4:15 PM ET
Wildfire Forces Cancelation of LD Micro Conference
Presentations Canceled for Celsius Holdings, Inc., GSI Technology, Inc., PCM, Inc., Simulations-Plus, ADOMANI, Inc., HUTN, Inc., NanoVibronix, Inc. and WidePoint Corp.
Simulations Plus Releases ADMET Predictor™ Version 8.5
New HTPK Simulation Module allows chemists to screen compound libraries using novel approach
Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results
Full Fiscal Year Pharmaceutical Software and Services Revenues Up 20.9%;
Earnings per share of $0.33, up 14.9% over prior year
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017
Company Reports Record Fourth-Quarter and Full-Year Revenues
Simulations Plus Releases MembranePlus™ Version 2
Major update incorporates new models and tighter integration with GastroPlus™
DILIsym Services Inc., a Simulations Plus Company, Releases DILIsym® Version 6A
Significant update of liver safety program includes performance and capability enhancements
Simulations Plus Sets Date for 3rd Quarter 2017 Earnings Release and Conference Call
Conference Call to be on Monday, July 10, 2017, at 4:15 PM ET
Simulations Plus Reports Third Quarter FY2017 Financial Results
Record quarter as revenues grow 12.2%, 9MoFY17 net income up 11.4%